Drug recall · June 12, 2024
Pregabalin Capsules 50mg recall
Why: Presence of Foreign Tablets/Capsules: Complaint received from a re-packager, American Health Packaging (AHP), where a foreign tablet was discovered in one of the bottles during packaging set up. Tablet identified as pantoprazole tablet 20mg.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Pregabalin Capsules 50mg, 1000-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc., East Brunswick, NJ 08816, Manufactured by: Laurus Labs Limited, Anakapalli-531011, India, NDC 64980-411-10
- Lots / codes
Lot: 23132611, Exp 07/31/2026
- Quantity
- N/A
- Company
- Rising Pharma Holding, Inc., East Brunswick, NJ
- Distribution
- Nationwide in the USA
- Initiated
- May 16, 2024 · Voluntary: Firm initiated
- Classified
- June 4, 2024
- Reported
- June 12, 2024
- How notified
- N/A
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Pregabalin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.